Late Stage Drug Development World 2009

1-4 December 2009, London, UK

Late stage drug development is growing at around 20% annually, exceeding the growth rate of Phase II and III Trials. In excess of $12 billion is currently being spent on Phase IIIb/IV studies as public concerns on the safety of approved drugs prevail together with the need to evaluate real world safety and effectiveness of marketed drugs. More than ever before there is the urgent need to detect, quantify and communicate patient risk with speed and efficiency. As a result, Health Network Communications is delighted to announce the first ever strategic forum addressing the major challenges in conducting strategic and compliant late stage studies.
More info >>

Fundraisers Get on TRAC Thanks to Sponsorship Support

Robert Eddy and Paul Brown, from Penzance, will be taking part in the annual Mongol Rally in July, a charity car trek, which will see them clock up over 10,000 miles, driving a third of the way around the world, through some of the most inhospitable areas of the Northern Hemisphere in their 10 year old car. But thanks to Redruth-based regulatory affairs specialist TRAC, which works with some of the world’s leading pharmaceutical companies, the challenge has already started on a positive note after the company donated £500.
More info >>